| Date Filed | Type | Description |
| 08/02/2023 |
4
| Harris Matthew Scott (Chief Medical Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 691 shares
@ $2.81, valued at
$1.9k
|
|
| 03/23/2023 |
4
| Harris Matthew Scott (Chief Medical Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Bought 10,000 shares
@ $4.22, valued at
$42.2k
|
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Harris Matthew Scott (Chief Medical Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 105,000 options to buy
@ $12.88, valued at
$1.4M
Granted 37,100 restricted stock units
@ $0 |
|
| 08/03/2022 |
4
| Harris Matthew Scott (Chief Medical Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 1,076 shares
@ $6.86, valued at
$7.4k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2020 |
4
| Harris Matthew Scott (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Sold 4,015 shares
@ $10.02, valued at
$40.2k
|
|
| 08/04/2020 |
4
| Harris Matthew Scott (Chief Medical Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 8,084 shares
@ $1.46, valued at
$11.8k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |